Which S&P500 stocks are the most active on Wednesday?
By Mill Chart
Last update: May 15, 2024
Which S&P500 stocks are the most active on Wednesday?
Today's most active stocks
| Ticker | Change | Comment |
|---|---|---|
| KVUE | -0.02% | The trading volume for KENVUE INC (NYSE:KVUE) has been quite high, with 69.26M shares exchanged. With a decline of 0.02%, NYSE:KVUE is facing a downward movement in its share price today. Yesterday the company had a press release: Kenvue Announces Pricing of Secondary Offering. |
| TSLA | -1.34% | The trading session for TESLA INC (NASDAQ:TSLA) has seen a substantial volume of 62.02M shares traded so far today. Leading to a price decrease of 1.34%. |
| AMZN | -1.1% | Today, there has been significant activity in the market for AMAZON.COM INC (NASDAQ:AMZN), with a total trading volume of 56.4M shares. NASDAQ:AMZN is declining 1.1% today. |
| AAPL | 1.48% | 38.67M shares of APPLE INC (NASDAQ:AAPL) have been traded so far today. NASDAQ:AAPL is advancing 1.48% today. Earlier today the company had a press release: Apple announces new accessibility features, including Eye Tracking, Music Haptics, and Vocal Shortcuts. |
| NVDA | 3.35% | The trading session for NVIDIA CORP (NASDAQ:NVDA) has been active, with a total volume of 29.28M shares traded so far today. Shares are rising by 3.35%. Earlier today the company had a press release: Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion Dollar Opportunities. |
| F | -1.57% | So far, a total of 29.2M shares of FORD MOTOR CO (NYSE:F) have been traded in today's session. Leading to a price decrease of 1.57%. Two days ago the company had a press release: Farley to Discuss Progress of Customer-Focused Ford+ Plan At May 30 Bernstein Annual Strategic Decisions Conference. |
| AMD | 3.6% | Investors have been actively buying and selling shares of ADVANCED MICRO DEVICES (NASDAQ:AMD) in today's session, resulting in a trading volume of 28.8M shares. The market is experiencing a notable price surge, with a rise of 3.6% across the board. Yesterday the company had a press release: AMD Announces Upcoming Events for the Financial Community. |
| CCL | 1.89% | Today, the market has shown strong interest in CARNIVAL CORP (NYSE:CCL) as 22.59M shares have already been traded. The market is experiencing a notable price surge, with a rise of 1.89% across the board. |
| PFE | 1.67% | So far, a total of 19.2M shares of PFIZER INC (NYSE:PFE) have been traded in today's session. The share price increased by 1.67%. |
| WBD | -3.91% | The trading volume for WARNER BROS DISCOVERY INC (NASDAQ:WBD) has reached 18.89M shares in today's session, reflecting significant market participation. The share price decreased by 3.91%. |
Our most active stocks screener will show you the full list.
PFIZER INC
NYSE:PFE (5/31/2024, 7:04:00 PM)
After market: 28.74 +0.08 (+0.28%)28.66
+0.46 (+1.63%)
PFE News
13 hours ago - InvestorPlace3 Discounted Stocks Poised for a Major UpswingExplore discounted upswing stocks with strong financials and strategic advantages heading for a rebound soon.
14 hours ago - InvestorPlaceBlue-Chip Blunders: 7 Stocks to Sell as Management Missteps MountSometimes top companies make bottom-shelf decisions; such is the case with these seven blue-chip stocks to sell.
a day ago - The Motley Fool3 Stocks to Buy for Huge IncomeAll 3 of these stocks have a yield above 5%.
2 days ago - Pfizer Inc.Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
2 days ago - Takeda Pharmaceutical Company LimitedTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
2 days ago - The Motley FoolIs Pfizer the Best Dividend Stock for You?Short-term expectation worries have elevated Pfizer's dividend yield.
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
2 days ago - Investor's Business DailyModerna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSKModerna's RSV vaccine will launch a year behind Pfizer and GSK, but it could become the market leader over the next five years.
2 days ago - Zacks Investment ResearchPfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2 days ago - CNBCFDA approves Moderna's RSV vaccine for seniors, the company's second-ever productThe decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
2 days ago - BusinessInsiderQUALCOMM To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
2 days ago - QuartzPfizer sees blockbuster potential for lung cancer drug Lorbrena after strong new data from phase 3 trialPfizer Chief Oncology Officer Chris Boshoff said the drug could reach $1 billion in annual sales by 2030
